Efficacy and Safety of IBI-10090 in Ocular Surgery Patients
NCT01606735
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
172
Enrollment
INDUSTRY
Sponsor class
Conditions
Inflammation Associated With Cataract Surgery
Interventions
DRUG:
IBI-10090
Sponsor
ICON Bioscience Inc